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Introduction
Although drug-eluting stents (DES) have significantly reduced 
the rate of restenosis by effectively suppressing neointimal growth 
compared with that of bare metal stents, complications such as in-
stent restenosis and stent thrombosis still occur. Stent fracture is 
also a complication of DES. The incidence of stent fracture is 1-8%.1) 
Most stent fractures are found in patients who were treated with a 
sirolimus-eluting stent.2)3) We experienced an unusual case of stent 
fracture after implantation of a zotarolimus-eluting stent (ZES), 
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Stent fracture is a complication following implantation of drug eluting stents and is recognized as one of the risk factors for in-stent re-
stenosis. We present the first case of successfully managing a stent fracture and subsequent migration of the fractured stent into the as-
cending aorta that occurred during repeat revascularization for in-stent restenosis of an ostium of saphenous vein graft after implanta-
tion of a zotarolimus-eluting stent. Although the fractured stent segment had migrated into the ascending aorta with a pulled balloon 
catheter, it was successfully repositioned in the saphenous vein graft using an inflated balloon catheter. Then, the fractured stent seg-
ment was successfully connected to the residual segment of the zotarolimus-eluting stent by covering it with an additional sirolimus-
eluting stent. (Korean Circ J 2012;42:58-61)
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which occurred during repeat revascularization for in-stent resteno-
sis lesions of a saphenous vein graft. 
Case 
A 72-year-old male underwent coronary artery bypass surgery 10 
years ago. He was free of symptoms for several years after the coro-
nary artery bypass surgery. One year ago, he suffered from exer-
tional chest pain and underwent a follow-up coronary angiogram. 
Coronary angiography showed two newly developed significant ste-
notic lesions with 80% luminal narrowing at the ostium and 90% lu-
minal narrowing at the mid-portion of the saphenous vein graft from 
the ascending aorta to the left anterior descending artery (Fig. 1A). 
The lesions were successfully treated with ZESs (3.5×15 and 3.0× 
30 mm, respectively) (Endeavor Resolute®, Medtronic, Santa Rosa, 
CA, USA) (Fig. 1B). He was discharged without any complications. 
Four months after stent implantation, he was admitted again due 
to exertional dyspnea. Coronary angiography revealed 90% in-stent 
restenosis at the ostium and a patent stent at the mid-portion of 
the saphenous vein graft (Fig. 1C). Fluoroscopic images showed an-
gulation of the proximal portions of the ZES at the ostium (Fig. 1D). 
After angioplasty with a cutting balloon catheter (3.25×15 mm) (Fig. 
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2A), the inflated balloon catheter was suddenly pulled back outside 
of the saphenous vein graft during adjunct balloon dilatation with 
a noncompliance balloon catheter (3.5×15 mm) (Fig. 2B). At the same 
time, a stent fracture occurred and the fractured stent segment and 
migrated into the ascending aorta along the inflated balloon cath-
eter (Fig. 2B). The migrated fractured struts were successfully pushed 
into the ostium of the saphenous vein graft without deflating the 
balloon catheter (Fig. 2C) and were inflated at higher inflation pres-
sure with the same noncompliance balloon catheter. Although a 
distal part of the fractured stent segment was attached to the osti-
um of the saphenous vein graft, a gap was evident between the frac-
tured stent segment and the residual stent, and a proximal part of 
the fractured stent segment was located outside of the saphenous 
vein graft (Fig. 2D). There was a potential for systemic stent emboliz-
ation of the fractured stent segment. Therefore, a sirolimus-eluting 
stent (3.5×18 mm) (CypherTM, Cordis, Miami, FL, USA) was deployed 
to connect the distal part of the fractured stent and the proximal 
part of the residual stent to prevent systemic stent embolization 
(Fig. 3A). Fluoroscopic images after implantation of the sirolimus-
eluting stent showed that the separated ZES segments were well 
connected without a gap after using an additional stent (Fig. 3B). 
The final angiogram with a noncompliance balloon catheter after ad-
junct angioplasty showed no residual stenosis (Fig. 3C). 
Discussion 
Stent fracture is sometimes observed after DES implantation. 
The most notable mechanisms of stent fracture are metal fatigue 
due to mechanical forces and shearing stress.1) The right coronary 
artery, tortuous vessels, and long stents are predictors of stent frac-
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Fig. 1. Two significantly stenotic lesions were detected in the saphenous vein graft from the ascending aorta to the left anterior descending artery; 80% lu-
minal narrowing at the ostium and 90% luminal narrowing at the mid-portion (A). These lesions were successfully treated with zotarolimus-eluting stent (ZES) 
(B). The 4-month follow-up angiogram after stent implantation showed 90% in-stent restenosis at the ostium and a patent stent at the mid-portion of 
the saphenous vein graft (C). Fluoroscopic images showed angulation (arrows with dotted line) of the proximal portion of the ZES at the ostium (D).
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Fig. 2. Balloon angioplasty with a cutting balloon catheter was performed (A) A stent fracture occurred during adjunct balloon dilatation with a noncom-
pliance balloon catheter and the fractured stent segment (two white thick arrows) had migrated into the ascending aorta along the inflated balloon cathe-
ter (B, arrow with dotted line: residual stent part). The migrated fractured struts were successfully pushed into the ostium of the saphenous vein graft 
without deflating the balloon catheter (C). Fluoroscopic image shows a gap between the fractured stent segment (black arrow with solid line) and the re-
sidual stent part (black arrow with dotted line) (D).
C  B  A  
Fig. 3. A sirolimus-eluting stent was deployed connect the distal part of the fractured stent (two white thick arrows) with the proximal part of the residual 
stent (arrow with dotted line) to prevent systemic stent embolization (A). Fluoroscopic images after implantation of the sirolimus-eluting stent showed 
that the separated zotarolimus-eluting stent segments were well connected without a gap using an additional stent (B). Final angiogram revealed no re-
sidual stenosis (C).
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ture.1)3)4) Additionally, stents implanted in saphenous venous grafts 
seem to be more susceptible to fracture.5) The type of implanted 
DESs is also strongly related to stent fracture. Of those, the sirolim-
us-eluting stent, which has a more rigid closed-cell stent design, has 
a tendency for more frequent fracture, compared with ZES, which 
has an open-cell stent design.2)3) 
In this case, we experienced a rare case of ZES fracture in an os-
tial in-stent restenostic lesion of the saphenous vein graft. Stent an-
gulation could be one of the contributing factors for stent fracture. 
Furthermore, balloon dilatation for repeat revascularization of in-
stent restenosis could be an additional aggravating mechanical 
force for stent fracture and separation of a DES implanted in an-
gulated segments. Because the fractured stent segment migrated 
with the dilated balloon catheter along the guidewire system, we 
easily moved this fractured segment into the remnant distal seg-
ments for re-union. This case shows how to manage the migration 
of a fractured ZES using balloon dilatation in a restenotic ostial le-
sion of a saphenous vein graft followed by additional DES implan-
tation.
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